Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

QLT0267 stops hair follicle cell growth and movement.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

Stem cell vesicles reduced eczema symptoms in mice safely.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

Innate lymphoid cells help us understand and manage allergic diseases better.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

High testosterone levels can harm fertility by disrupting the LIF signaling pathway in the uterus.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

MM-CEP/NLCs could effectively treat lung inflammation.

Calancardin B may help reduce inflammation in immune cells.

RNase L hinders hair follicle regeneration by altering immune signals.

Type I interferons play a key role in the development of various skin diseases.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

A(1-7) treatment reduces symptoms of lupus in mice.

Tislelizumab can cause cutaneous lupus erythematosus.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.